Anumana’s innovative AI algorithms recognized for their transformative potential in cardiology - the first of which is now commercially available “At Anumana, we are committed to developing ...

The 12-lead ECG hasn't changed in a century. The algorithms reading it have. Three CEOs and one educator on whether doctors should trust the model ...

A new clinical study shows that PulseAI’s deep learning AI demonstrates superiority over the Apple Watch ECG in the detection of atrial fibrillation. Results have been accepted for presentation at the ...

Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI(TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...

Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device ...

An artificial intelligence (AI) algorithm paired with the single-lead electrocardiogram (ECG) sensors on a smartwatch accurately diagnosed structural heart diseases, such as weakened pumping ability, ...

Clinicians rely daily on electrocardiograms (ECG) to detect common cardiovascular conditions, but accurate diagnoses require high levels of expertise. In a new study that reviewed nearly 1 million ...

An artificial intelligence (AI) deep-learning algorithm interpreting preoperative ECGs can identify risk for postoperative death in those undergoing cardiac surgery, noncardiac surgery, and ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, announced today it has received the 2024 MedTech Breakthrough Award ...

CAMBRIDGE, Mass., April 08, 2026--(BUSINESS WIRE)--Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac ...